Trials / Sponsors / BrightPath Biotherapeutics
BrightPath Biotherapeutics
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | GRN-1201 With Pembrolizumab in Subjects With Metastatic PD-L1+ NSCLC Metastatic NSCLC | Phase 2 | 2019-01-03 |
| Completed | Phase 1 Study of GRN-1201 in HLA-A*02 Subjects With Resected Melanoma Melanoma | Phase 1 | 2016-04-01 |